Similar articles

• Autoimmune disease: immunotherapy by peptides?

  Janeway CA. Janeway CA. Nature. 1989 Oct 12;341(6242):482-3. doi: 10.1038/341482a0. Nature. 1989. PMID: 2477706 No abstract available.
• Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis.

  Vandenbark AA, Hashim G, Offner H. Vandenbark AA, et al. Nature. 1989 Oct 12;341(6242):541-4. doi: 10.1038/341541a0. Nature. 1989. PMID: 2477708
• [The trimolecular complex as a target for specific immunotherapy in experimental autoimmune encephalomyelitis--applications for multiple sclerosis and other human autoimmune disease].

  Miller A, Weiner HL, Abramsky O. Miller A, et al. Harefuah. 1992 Aug;123(3-4):110-5. Harefuah. 1992. PMID: 1516860 Review. Hebrew. No abstract available.
• The autoimmune T-cell receptor in experimental disease.

  Heber-Katz E. Heber-Katz E. Immunol Ser. 1991;55:155-69. Immunol Ser. 1991. PMID: 1954284 Review. No abstract available.
• Fine T cell receptor repertoire analysis of spinal cord T cells responding to the major and minor epitopes of myelin basic protein during rat autoimmune encephalomyelitis.

  Matsumoto Y, Jee Y, Sugisaki M, Kim G, Tanuma N. Matsumoto Y, et al. J Neurosci Res. 2000 Jan 1;59(1):145-52. J Neurosci Res. 2000. PMID: 10658195